Impact of thrombus aspiration during primary percutaneous coronary intervention on mortality in ST-segment elevation
Awsan Noman1, Mohaned Egred, Alan Bagnall
1Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, UK.
Insights
Thrombus aspiration during primary percutaneous coronary intervention (PPCI) significantly reduces mortality in ST-elevation myocardial infarction (STEMI) patients, particularly those with shorter ischemic times. This supports using thrombectomy in PPCI for eligible STEMI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- ST-elevation myocardial infarction (STEMI) is a critical condition requiring immediate intervention.
- Primary percutaneous coronary intervention (PPCI) is the standard treatment for STEMI.
- Thrombus burden can impact PPCI outcomes.
Purpose of the Study:
- To evaluate the effect of thrombus aspiration during PPCI on mortality in STEMI patients.
- To determine if thrombus aspiration improves outcomes in STEMI treatment.
Main Methods:
- Retrospective analysis of 2567 STEMI patients undergoing PPCI.
- Utilized Cox proportional hazard models and logistic regression for covariate adjustment.
- Compared outcomes between patients who underwent thrombectomy and those who did not.
Main Results:
- Thrombectomy was performed in 42.7% of patients.
- Achieved better post-PPCI thrombolysis in myocardial infarction 3 flow.
- Associated with significant reductions in in-hospital and longer-term mortality.
- Benefit was most pronounced in patients with ischemic times ≤180 minutes.
Conclusions:
- Thrombus aspiration during PPCI significantly reduces mortality in unselected STEMI patients.
- The benefit of thrombectomy is particularly evident in patients with shorter ischemic times.
- Supports the routine use of thrombectomy during PPCI for selected STEMI patients.
Aims:
To assess the impact of thrombus aspiration during primary percutaneous coronary intervention (PPCI) on the mortality of patients with ST-elevation myocardial infarction (STEMI) patients.
Methods And Results:
Retrospective analysis of prospectively collected data on 2567 consecutive PPCI-treated STEMI patients between 2008 and 2011. Cox proportional hazard models and multiple logistic regression analysis were used to adjust for known covariates. Thrombectomy was performed in 1095 patients (42.7%). Post-PPCI thrombolysis in myocardial infarction 3 flow was more frequently achieved in the thrombectomy group [adjusted odds ratio (OR); 1.92, 95% confidence interval (CI): 1.34-2.76, P = 0.0004]. Overall in-hospital and longer term (mean follow-up 9.9 months) mortality rates were 4.5 and 9.0%, respectively. Thrombectomy was associated with a significant reduction in in-hospital (adjusted OR: 0.51, 95% CI: 0.29-0.93, P = 0.027) and longer term mortality [adjusted hazard ratio (HR): 0.69, 95% CI: 0.48-0.96, P = 0.028]. With propensity weighting, the adjusted HR for longer term mortality for thrombectomy was 0.43 (95% CI: 0.19-0.97; P = 0.042). The association between thrombectomy and reduced longer term mortality was only significant in those with a total ischaemic time ≤180min (P = 0.001) but not in patients with a total ischaemic time >180min (P = 0.99).
Conclusion:
This study of real-world, unselected STEMI patients demonstrates that thrombus aspiration during PPCI is associated with a significant reduction in mortality, especially in those with a short total ischaemic time. These findings support the use of thrombectomy during PPCI in this group of patients.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
